Summary:
Clinical research study to evauate an investigational medication on slowing progression of mild cognitive impairment due to possible Alzheimer's disease.
Qualified Participants Must:
Be between 55 and 85 years of age
Have mild cognitive impairment due to possible Alzheimer's disease
Qualified Participants May Receive:
- All study medication and procedures at no cost
- Compensation for time and travel